TAKE Steps: a pilot randomized controlled trial of an adolescent sexually transmitted infection (STI) and HIV prevention intervention
Our primary aim was to assess the Treat Act Know Engage (TAKE) Steps intervention’s effect on sexually transmitted infection (STI) and HIV prevention self-efficacy, a hypothesized mediator of intervention effect. Secondarily, we aimed to measure HIV prevention behavior outcomes and intervention feasibility and acceptability. This pilot randomized controlled trial enrolled 13–19 year-olds with STIs at Philadelphia-area pediatric clinics, 2022–2024. Participants were randomized to TAKE Steps, a four-session motivational interviewing, communication skill-building and navigation intervention or enhanced usual care (EUC; quarterly text message-based STI/HIV testing reminders.) Mixed effects linear regression compared between-arm self-efficacy score changes from baseline to three months (primary outcome). We measured feasibility as proportions of eligible patients enrolled and intervention participants retained. One-week and three-month surveys measured acceptability. Chi-squared testing compared prevention behavior between arms. Forty-two intervention and 40 EUC participants were 96% Black and 90% female. Regarding our primary endpoint, there were no significant between-group self-efficacy differences over time (+ 1.67, − 0.89, 4.23). Recruitment feasibility was 15% and we retained 67% of intervention participants. Acceptability was 96%. At six months, more intervention than EUC participants completed STI retesting (80% vs 58%, p = 0.03) and HIV testing (63% vs 45%, p = 0.11). Three intervention and no EUC participants initiated HIV pre-exposure prophylaxis by three months (p = 0.11). TAKE Steps is a promising and highly acceptable STI and HIV prevention intervention. Participation led to increased intervention group, but not between-group self-efficacy and uptake of STI and HIV testing. Future research should optimize recruitment and retention and examine behavioral mediators. ClinicalTrials.gov. NCT05215262.
Authors
- Nadia Dowshen (ORCID: https://orcid.org/0000-0002-8466-1628)
- Rinad S. Beidas (ORCID: https://orcid.org/0000-0001-6056-6071)
- Alexander G. Fiks (ORCID: https://orcid.org/0000-0001-6525-8764)
- Molly Davis (ORCID: https://orcid.org/0000-0001-5959-3558)
- Jungwon Min (ORCID: https://orcid.org/0000-0002-5518-9782)
- Karen T. G. Schwartz (ORCID: https://orcid.org/0000-0003-4036-0281)
- Sarah M. Wood (ORCID: https://orcid.org/0000-0003-2478-4930)
- Jami F. Young (ORCID: https://orcid.org/0000-0002-7488-5097)
- José A. Bauermeister (ORCID: https://orcid.org/0000-0002-9276-2306)
- Mikia Croom
- Robert Gross (ORCID: https://orcid.org/0000-0001-6066-1159)
- Haley Belardo
- Elizabeth Odunaiya
- Naomi Pressman (ORCID: https://orcid.org/0000-0003-0231-3222)
Institutions
- Northwestern University (US)
- Children's Hospital of Philadelphia (US)
- Arcadia University (US)
- University of Pennsylvania (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Pilot and Feasibility Studies
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1186/s40814-026-01965-w
- Primary Topic
- Adolescent Sexual and Reproductive Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00